Document Detail


Benzodiazepine withdrawal: overview and implications for the treatment of anxiety.
MedLine Citation:
PMID:  2897789     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The authors critically review 20 reports (studies and large case series) detailing the nature, severity, and variability of benzodiazepine withdrawal syndromes. Factors affecting the frequency and intensity of withdrawal are identified, and methodologic problems limiting the generalizability of certain findings are pointed out. Treatment approaches for minimizing withdrawal are reviewed, and implications for the problem of long-term benzodiazepine use and dependence are discussed.
Authors:
P P Roy-Byrne; D Hommer
Related Documents :
15020449 - Bayesian estimation of genomic distance.
24284289 - Leflunomide-induced interstitial lung disease (a systematic review).
10645559 - Nine more cases of human infections by dirofilaria repens diagnosed in italy by morphol...
23424229 - Clinical relevance of linezolid-associated serotonin toxicity (march).
18718379 - Apical actinomycosis as a continuum of intraradicular and extraradicular infection: cas...
11159929 - Survival and recovery: psychoanalytic reflections.
12625889 - Carbon monoxide poisoning and sensorineural hearing loss.
24824199 - Poor reliability between cochrane reviewers and blinded external reviewers when applyin...
2657709 - Congenital cystic hygroma of the neck diagnosed prenatally: outcome with normal and abn...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The American journal of medicine     Volume:  84     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  1988 Jun 
Date Detail:
Created Date:  1988-06-28     Completed Date:  1988-06-28     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1041-52     Citation Subset:  AIM; IM    
Affiliation:
Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Anxiety Agents / adverse effects*,  therapeutic use
Anxiety Disorders / drug therapy
Benzodiazepines
Humans
Substance Withdrawal Syndrome* / physiopathology,  therapy
Chemical
Reg. No./Substance:
0/Anti-Anxiety Agents; 12794-10-4/Benzodiazepines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Amelioration of vincristine neurotoxicity by glutamic acid.
Next Document:  Diagnosis of classical steroid 21-hydroxylase deficiency using an HLA-B locus-specific DNA-probe.